S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
NASDAQ:DRTS

Alpha Tau Medical (DRTS) Stock Price, News & Analysis

$2.95
-0.02 (-0.67%)
(As of 03/27/2024 ET)
Today's Range
$2.94
$3.03
50-Day Range
$2.84
$3.35
52-Week Range
$2.70
$4.80
Volume
10,308 shs
Average Volume
25,568 shs
Market Capitalization
$205.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00

Alpha Tau Medical MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
306.8% Upside
$12.00 Price Target
Short Interest
Healthy
0.07% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.29mentions of Alpha Tau Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.52) to ($0.56) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.84 out of 5 stars

Medical Sector

774th out of 939 stocks

Surgical & Medical Instruments Industry

83rd out of 99 stocks

DRTS stock logo

About Alpha Tau Medical Stock (NASDAQ:DRTS)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

DRTS Stock Price History

DRTS Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Analyst Ratings for Alpha Tau Medical
Alpha Tau Medical GAAP EPS of $0.31
Recap: Alpha Tau Medical Q1 Earnings
Alpha Tau Medical Ltd (DRTS) Receives a Buy from H.C. Wainwright
See More Headlines
Receive DRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpha Tau Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/07/2024
Today
3/28/2024
Next Earnings (Estimated)
5/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:DRTS
Fax
N/A
Employees
121
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.00
High Stock Price Target
$23.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+306.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-29,160,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.21 per share

Miscellaneous

Free Float
42,151,000
Market Cap
$205.53 million
Optionable
Optionable
Beta
0.70
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Uzi Sofer (Age 54)
    CEO & Chairman
    Comp: $630k
  • Mr. Raphi Levy (Age 39)
    Chief Financial Officer
    Comp: $424k
  • Mr. Amnon Gat (Age 49)
    Chief Operations Officer
    Comp: $340k
  • Mr. Peter M. Melnyk (Age 62)
    Chief Commercial Officer
    Comp: $376k
  • Dr. Robert B. Den M.D. (Age 45)
    Chief Medical Officer & Member of Scientific Advisory Board
    Comp: $401k
  • Mr. Ronen Segal (Age 51)
    Chief Technology Officer
    Comp: $380k
  • Prof. Yona Keisari (Age 77)
    Chief Scientific Officer & Member of Scientific Advisory board
  • Ms. Rebecca Becker
    Vice President of legal
  • Prof. Itzhak Kelson (Age 84)
    Chief Physics Officer & Member of Scientific Advisory Board
  • Ms. Yael Zeiger (Age 41)
    Corporate Controller

DRTS Stock Analysis - Frequently Asked Questions

Should I buy or sell Alpha Tau Medical stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alpha Tau Medical in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DRTS shares.
View DRTS analyst ratings
or view top-rated stocks.

What is Alpha Tau Medical's stock price target for 2024?

4 analysts have issued 1-year target prices for Alpha Tau Medical's stock. Their DRTS share price targets range from $8.00 to $23.00. On average, they predict the company's stock price to reach $12.00 in the next year. This suggests a possible upside of 306.8% from the stock's current price.
View analysts price targets for DRTS
or view top-rated stocks among Wall Street analysts.

How have DRTS shares performed in 2024?

Alpha Tau Medical's stock was trading at $3.01 on January 1st, 2024. Since then, DRTS stock has decreased by 2.0% and is now trading at $2.95.
View the best growth stocks for 2024 here
.

Are investors shorting Alpha Tau Medical?

Alpha Tau Medical saw a increase in short interest in March. As of March 15th, there was short interest totaling 34,900 shares, an increase of 22.5% from the February 29th total of 28,500 shares. Based on an average daily volume of 34,500 shares, the short-interest ratio is presently 1.0 days. Currently, 0.1% of the shares of the company are short sold.
View Alpha Tau Medical's Short Interest
.

When is Alpha Tau Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024.
View our DRTS earnings forecast
.

How were Alpha Tau Medical's earnings last quarter?

Alpha Tau Medical Ltd. (NASDAQ:DRTS) posted its earnings results on Thursday, March, 7th. The company reported ($0.11) EPS for the quarter, topping analysts' consensus estimates of ($0.13) by $0.02.

Who are Alpha Tau Medical's major shareholders?

Alpha Tau Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Levin Capital Strategies L.P. (0.48%), Private Advisor Group LLC (0.08%), Satovsky Asset Management LLC (0.08%), Telemus Capital LLC (0.04%), Northern Trust Corp (0.04%) and LM Advisors LLC (0.02%).

How do I buy shares of Alpha Tau Medical?

Shares of DRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DRTS) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners